FORTHCOMING DEADLINE: J&W Announces Class Action Suit against Foundation Medicine, Inc.; Investors Encouraged to Contact Firm
SAN DIEGO- PRNewswire —September 2, 2017
Johnson & Weaver, LLP reminds investors that a class action case was filed against Foundation Medicine, Inc. (NASDAQ: FMI) (“Foundation Medicine “) for purchasers of the stock between February 26, 2014 through November 3, 2015, inclusive (the “Class Period”).
The complaint filed in this class action alleges that the defendants made false and misleading statements regarding; (1) the reimbursement process and likelihood of coverage for Foundation Medicine’s tumor tests by Medicare; and (2) Foundation Medicine’s financial guidance. As a result of these alleged false statements, Foundation Medicine common stock traded at artificially inflated prices during the Class Period.
If you purchased shares during the Class Period and suffered a loss in Foundation Medicine, you have until September 26, 2017 to request that the Court appoint you as lead plaintiff.
If you are a long-term shareholder of Foundation Medicine shares and continuously held shares before February 26, 2014, you may have standing to hold Foundation Medicine harmless from the damage the officers and directors may have caused by making them personally responsible. You may also be able to assist in reforming the Company’s corporate governance to prevent future wrongdoing.
If you are a Foundation Medicine shareholder and are interested in learning more about your legal rights and remedies, please contact Jim Baker (email@example.com) at 619-814-4471. If you email, please include your phone number.
About Johnson & Weaver, LLP:
Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.
Johnson & Weaver, LLP
Jim Baker, 619-814-4471